Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-042874
Filing Date
2021-06-23
Accepted
2021-06-23 21:09:55
Documents
1
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6180
  Complete submission text file 0001209191-21-042874.txt   7548
Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Makhzoumi Mohamad (Reporting) CIK: 0001630226 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40522 | Film No.: 211040330

Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)